ADMA
ADMA Biologics Inc
Company Overview
| Mkt Cap | $3.72B | Price | $15.48 |
| Volume | 2.49M | Change | +1.38% |
| P/E Ratio | 18.8 | Open | $15.20 |
| Revenue | $426.5M | Prev Close | $15.27 |
| Net Income | $197.7M | 52W Range | $13.50 - $25.67 |
| Div Yield | N/A | Target | $30.67 |
| Overall | 48 | Value | 60 |
| Quality | -- | Technical | 36 |
No chart data available
Stock Overview
Updated DailyADMA Biologics Inc (ADMA) is a leading Healthcare company in the Biotechnology industry, currently trading at $15.48 with a market capitalization of $3.72 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ADMA with a volume of 2.49 million shares. The stock opened down 0.46% from yesterday's close of $15.27. Current analyst estimates project earnings of $0.63 per share for this year, with next year targeting $0.88.
ADMA demonstrates concerning technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including NVAX, RGEN, CVM.
Key investment considerations for ADMA include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 98.1%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 04:08 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ADMA | $15.48 | +1.4% | 2.49M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |